Summary

Preterm Birth And PROM Testing Market Growth & Trends

The global preterm birth and PROM testing market size is expected to reach USD 1.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.0% from 2021 to 2028. Key factors that can be attributed to market growth are rising number of preterm births in developed and emerging economies, improving access to advanced neonatal and maternal care facilities, and introduction of new POC diagnostic products over the forecast period.

Preterm births are not specific to a particular geography and have been recognized as a worldwide concern. The risk of preterm births typically escalates with increasing average age of pregnant women. With growing awareness about preterm births and its consequence, the tendency of pregnant women to enroll for Premature Rupture of Membranes (PROM) testing during their pregnancy is anticipated to increase, for reassurance and monitoring of symptoms of preterm birth.

Point-of-Care (POC) diagnostics have drastically altered the methodology of testing in various fields. With the help of advanced technology, devices are able to assess analytes in a given sample. Companies are focusing on R&D to increase specificity and sensitivity of devices, which lowers the error rate. Hence, emphasis is being given to reducing sample size required for other medical testing.

Many low-income states like Bihar, Madhya Pradesh, Rajasthan, and Uttar Pradesh have low utilization of public healthcare services for female infants. Despite the availability of free healthcare services, only approximately 41% of admissions to the SNCUs are female infants. Hence, many states have banned gender revelation to the family before birth. India is the only large country where more female infants die than males. UNICEF plans to intervene by strengthening the health infrastructure, and reducing inequities of healthcare services, and improve healthcare outcomes.

Preterm Birth And PROM Testing Market Report Highlights

• By test type, the ultrasound segment dominated the market in 2020, as it is one of the most preferred technologies for tracking fetal development and maternal health

• Techniques such as Placental Alpha-Microglobulin-1 (PAMG-1) are gaining prominence due to better reliability in predicting the risk of preterm births

• North America held the largest revenue share in 2020 owing to higher incidence of pregnancies in the above 35 years age group and well-developed infrastructure to manage high-risk pregnancies

• As per the American College of Obstetricians and Gynecologists (ACOG), in the U.S., nearly 12.0% of childbirths are preterm, which lead to higher hospitalization and treatment costs

• In Asia Pacific, the market is projected to witness the highest CAGR over the forecast period. This can be attributed to high population growth in countries such as India and China

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Preterm Birth and PROM Testing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing average age of pregnant women, leading to exponential rise in the number of preterm births
3.3.1.2 Improvement in point-of-care diagnostics
3.3.1.3 Social and economic factors
3.3.2 Market Restraint Analysis
3.3.2.1 Product recalls and adverse effects
3.3.2.2 High cost and unmet needs
3.4 Preterm Birth and PROM Testing Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
Chapter 4 Preterm Birth and PROM Testing Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2020
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Preterm Birth and PROM Testing Market: Test Type Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Test Type Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Preterm Birth and PROM Testing Market, by Test Type, 2016 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.5.1 Pelvic Exam
5.5.1.1 Pelvic Exam Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.2 Ultrasound
5.5.2.1 Ultrasound Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3 Biochemical Markers
5.5.3.1 Biochemical Markers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3.2 Interleukin (IL)-6
5.5.3.2.1 Interleukin (IL)-6 Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3.3 C-Reactive Protein (CRP)
5.5.3.3.1 C-Reactive Protein (CRP) Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3.4 IL-1, IL-2, IL-8, TNF-a
5.5.3.4.1 IL-1, IL-2, IL-8, TNF-a Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3.5 Corticotropin-Releasing Hormone (CRH)
5.5.3.5.1 Corticotropin-Releasing Hormone (CRH) Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3.6 Alpha-fetoprotein (AFP)
5.5.3.6.1 Alpha-fetoprotein (AFP) Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.4 Uterine Monitoring
5.5.4.1 Uterine Monitoring Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.5 Nitazine Test
5.5.5.1 Nitazine Test Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.6 Ferning Test
5.5.6.1 Ferning Test Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.7 Pooling
5.5.7.1 Pooling Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.8 PAMG-1 Immunoassay
5.5.8.1 PAMG-1 Immunoassay Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.9 IGFBP Test
5.5.9.1 IGFBP Test Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.10 Fetal Fibronectin (fFN)
5.5.10.1 Fetal Fibronectin (fFN) Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.11 Others
5.5.11.1 Others Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 6 Preterm Birth and PROM Testing Market: Regional Estimates & Trend Analysis
6.1 Regional Market Snapshot
6.2 Regional Market Share and Leading Players, 2020
6.2.1 North America
6.2.2 Europe
6.2.3 Latin America
6.2.4 Asia Pacific
6.2.5 Middle East & Africa
6.3 Market Share Analysis by Country, 2020
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.2.1 U.K.
6.3.2.2 Germany
6.3.2.3 Spain
6.3.2.4 France
6.3.2.5 Italy
6.3.2.6 Russia
6.3.3 Latin America
6.3.3.1 Brazil
6.3.3.2 Mexico
6.3.3.3 Argentina
6.3.4 Asia Pacific
6.3.4.1 Japan
6.3.4.2 China
6.3.4.3 India
6.3.4.4 Australia
6.3.4.5 South Korea
6.3.4.6 Singapore
6.3.5 Middle East & Africa
6.3.5.1 South Africa
6.3.5.2 Saudi Arabia
6.3.5.3 UAE
6.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.4.1 North America
6.4.2 Europe
6.4.3 Latin America
6.4.4 Asia Pacific
6.4.5 Middle East & Africa
6.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2028
6.5.1 North America
6.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.1.2 U.S.
6.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.1.3 Canada
6.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.2 Europe
6.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.2.2 U.K.
6.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.2.3 Germany
6.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.2.4 Spain
6.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.2.5 France
6.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.2.6 Italy
6.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.2.7 Russia
6.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.3 Latin America
6.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.3.2 Brazil
6.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.3.3 Mexico
6.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.3.4 Argentina
6.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.4 Asia Pacific
6.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.4.2 Japan
6.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.4.3 China
6.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.4.4 India
6.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.4.5 Australia
6.5.4.5.1 Australia Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.4.6 South Korea
6.5.4.6.1 South Korea Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.4.7 Singapore
6.5.4.7.1 Singapore Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.5 Middle East & Africa
6.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.5.2 South Africa
6.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.5.3 Saudi Arabia
6.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
6.5.5.4 UAE
6.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD million)
Chapter 7 Company Profiles
7.1 Company Profiles
7.1.1 Qiagen N.V.
7.1.1.1 Company overview
7.1.1.2 Financial Performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Hologic, Inc.
7.1.2.1 Company overview
7.1.2.2 Financial Performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Cooper Surgical Inc.
7.1.3.1 Company overview
7.1.3.2 Financial Performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Abbott
7.1.4.1 Company overview
7.1.4.2 Financial Performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Medixbiochemica
7.1.5.1 Company overview
7.1.5.2 Financial Performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Sera prognostics
7.1.6.1 Company overview
7.1.6.2 Financial Performance
7.1.6.3 Product benchmarking
7.1.6.4 Strategic initiatives
7.1.7 Clinical Innovations, LLC
7.1.7.1 Company overview
7.1.7.2 Financial Performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Biosynex
7.1.8.1 Company overview
7.1.8.2 Financial Performance
7.1.8.3 Product benchmarking
7.1.8.4 Strategic initiatives
7.1.9 NX Prenatal, Inc.
7.1.9.1 Company overview
7.1.9.2 Financial Performance
7.1.9.3 Product benchmarking
7.1.9.4 Strategic initiatives
7.1.10 IQ Products
7.1.10.1 Company overview
7.1.10.2 Financial Performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives


List of Tables

Table 1 List secondary sources
Table 2 North America preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 3 North America preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 4 U.S. preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 5 U.S. preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 6 Canada preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 7 Canada preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 8 Europe preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 9 Europe preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 10 Germany preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 11 Germany preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 12 U.K. preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 13 U.K. preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 14 France preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 15 France preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 16 Italy preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 17 Italy preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 18 Spain preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 19 Spain preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 20 Russia preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 21 Russia preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 22 Asia Pacific preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 23 Asia Pacific preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 24 Japan preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 25 Japan preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 26 China preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 27 China preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 28 India preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 29 India preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 30 Australia preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 31 Australia preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 32 South Korea preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 33 South Korea preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 34 Singapore preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 35 Singapore preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 36 Latin America preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 37 Latin America preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 38 Brazil preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 39 Brazil preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 40 Mexico preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 41 Mexico preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 42 Argentina preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 43 Argentina preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 44 MEA preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 45 MEA preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 46 South Africa preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 47 South Africa preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 48 Saudi Arabia preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 49 Saudi Arabia preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)
Table 50 UAE preterm birth and PROM testing market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 51 UAE preterm birth and PROM testing market estimates and forecasts, by biochemical markers, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot, 2020 (USD Million)
Fig. 9 Preterm birth and PROM testing market segmentation
Fig. 10 Penetration & growth prospect mapping for test type, 2020
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Company/competition categorization (key innovators, market leaders, emerging players)
Fig. 14 Strategy framework
Fig. 15 Market participation categorization
Fig. 16 Company position analysis
Fig. 17 Preterm birth and PROM testing market: Test type outlook and key takeaways
Fig. 18 Preterm birth and PROM testing market: Test type movement analysis
Fig. 19 Pelvic exam market, 2016 - 2028 (USD Million)
Fig. 20 Ultrasound market, 2016 - 2028 (USD Million)
Fig. 21 Biochemical markers market, 2016 - 2028 (USD Million)
Fig. 22 Interleukin (IL)-6 market, 2016 - 2028 (USD Million)
Fig. 23 C-Reactive Protein (CRP) market, 2016 - 2028 (USD Million)
Fig. 24 IL-1, IL-2, IL-8, TNF-a market, 2016 - 2028 (USD Million)
Fig. 25 Corticotropin-Releasing Hormone (CRH) market, 2016 - 2028 (USD Million)
Fig. 26 Alpha-fetoprotein (AFP) market, 2016 - 2028 (USD Million)
Fig. 27 Uterine monitoring market, 2016 - 2028 (USD Million)
Fig. 28 Nitazine test market, 2016 - 2028 (USD Million)
Fig. 29 Ferning test market, 2016 - 2028 (USD Million)
Fig. 30 Pooling market, 2016 - 2028 (USD Million)
Fig. 31 PAMG-1 immunoassay market, 2016 - 2028 (USD Million)
Fig. 32 IGFBP test market, 2016 - 2028 (USD Million)
Fig. 33 Fetal Fibronectin (fFN) market, 2016 - 2028 (USD Million)
Fig. 34 Others market, 2016 - 2028 (USD Million)
Fig. 35 Preterm birth and PROM testing market: Regional outlook and key takeaways
Fig. 36 Preterm birth and PROM testing market: Regional movement analysis
Fig. 37 North America
Fig. 38 North America preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 U.S.
Fig. 40 U.S. preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 Canada
Fig. 42 Canada preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 Europe
Fig. 44 Europe preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 Germany
Fig. 46 Germany preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 U.K.
Fig. 48 U.K. preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 France
Fig. 50 France preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 51 Italy
Fig. 52 Italy preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 53 Spain
Fig. 54 Spain preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 55 Russia
Fig. 56 Russia preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 57 Asia Pacific
Fig. 58 Asia Pacific preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 59 Japan
Fig. 60 Japan preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 61 China
Fig. 62 China preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 63 India
Fig. 64 India preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 65 Australia
Fig. 66 Australia preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 67 South Korea
Fig. 68 South Korea preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 69 Singapore
Fig. 70 Singapore preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 71 Latin America
Fig. 72 Latin America preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 73 Brazil
Fig. 74 Brazil preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 75 Mexico
Fig. 76 Mexico preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 77 Argentina
Fig. 78 Argentina preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 79 MEA
Fig. 80 MEA preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 81 South Africa
Fig. 82 South Africa preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 83 Saudi Arabia
Fig. 84 Saudi Arabia preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 85 UAE
Fig. 86 UAE preterm birth and PROM testing market estimates and forecast, 2016 - 2028 (USD Million)